Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedWellAIMWAI 6 12-1 Month Momentum % is -57.92% as of Jul. 23, 2026. GuruFocus rates MWAI with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 825 Capital Markets companies, MedWellAI ranks worse than 92.12% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-23), MedWellAI's 12-1 Month Momentum % is -57.92%.
The industry rank for MedWellAI's 12-1 Month Momentum % or its related term are showing as below:
MWAI's 12-1 Month Momentum % is ranked worse than 92.12% of 825
companies
in the Capital Markets industry
Industry Median: -8.06
vs MWAI: -57.92
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MedWellAI 12-1 Month Momentum % Related Terms
MWAI vs IPST, BTMCQ, LMFA: 12-1 Month Momentum % Comparison
For the Capital Markets subindustry, MedWellAI's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedWellAI 12-1 Month Momentum % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, MedWellAI's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MedWellAI's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -57.92% mean?
MedWellAI (MWAI) has a 12-1 Month Momentum % of -57.92% as of Jul. 23, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MedWellAI and its competitors. According to the industry distribution chart, MedWellAI ranks #760 out of 825 companies in the Capital Markets industry, placing it in the top 92.1%.
Is MedWellAI's 12-1 Month Momentum % too high?
MedWellAI's current 12-1 Month Momentum % is -57.92%. Based on the distribution chart, MedWellAI ranks #760 out of 825 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, MedWellAI has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does MedWellAI's 12-1 Month Momentum % compare to IPST and BTMCQ?
According to the Capital Markets industry distribution chart, MedWellAI ranks #760 out of 825 companies for 12-1 Month Momentum %. This places MedWellAI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Capital Markets company?
A good 12-1 Month Momentum % depends on the Capital Markets industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MedWellAI and its competitors. MedWellAI's current 12-1 Month Momentum % is -57.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedWellAI stock overvalued right now?
MedWellAI (MWAI) has a current 12-1 Month Momentum % of -57.92%. The current 12-1 Month Momentum % is -57.92%. MedWellAI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For MedWellAI (MWAI), the current 12-1 Month Momentum % is -57.92% as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedWellAI Inc is a holding company focused on AI-driven healthcare and wellness solutions, offering a B2B platform for GLP medications with real-time inventory and provider support. The company operates as a single operating segment, focusing on acquiring, launching, and operating companies in the rapidly growing health and wellness sector.
6GF Score
Get the complete analysis for MWAI
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MWAI has been successfully added to your 
